Journal
CHINESE CHEMICAL LETTERS
Volume 29, Issue 3, Pages 417-422Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2017.08.040
Keywords
Swainsonine; Indolizine; Biosynthesis; Isotope-labeled; Gene Cluster
Categories
Funding
- National Natural Science Foundation of China [31570340]
- National Key Research and Development Program of China [2017ZX09101003-006-006]
- Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Agricultural Sciences [502-17]
Ask authors/readers for more resources
Swainsonine (1) belongs to the family, of indolizine alkaloid with strong neurologically toxic effects on herbivorous livestock. Recently, a great amount of evidence confirmed that this alkaloid displayed a wide range of bioactivities especially anti-cancer biological effects. The potential targets of swainsonine (1) were now revealed to be the mannosidase and Golgi mannosidase. IL Its low yield in plants or fungi, and no economically total synthesis route in practice as the key bottleneck restricted its further structure activities relationships (SAR) investigation in drug discovery. This mini-review highlighted the biosynthetic advance of swainsonine (1) from 1973 to 2017 based on the results of isotope-labelled experiments and the recent research of its biosynthetic gene duster, which could provide some thoughts for further biosynthetic investigation and efficiently biomimetic synthesis of swainsonine (1) in order to increase its output in practice. (C) 2017 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available